Cited by 183Research on Leishmaniasis StudiesLeprosy Research and TreatmentParasites and Host Interactions

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Tumor necrosis factor‐α in combination with interferon‐γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

Open access

Bogdan, Christian, Moll, Heidrun, Solbach, Werner, Röllinghoff, Martin·1990·European Journal of Immunology

DOI 10.1002/eji.1830200528

Open this paper in CoChat — free account Open PDF

Abstract

We have previously shown that during an infection with Leishmania major, susceptible BALB/c mice, as opposed to mice of a resistant strain (C57BL/6), are primed by lipopolysaccharide for the production of high levels of tumor necrosis factor‐α (TNF‐α) which is known to be a potent macrophage (MΦ) stimulator in other parasitic diseases. In the present study we investigated whether TNF‐α activates MΦ for killling of L. major parasites. In the absence of interferon‐γ (IFN‐γ) or lipopolysaccharide, TNF‐α (0.025—25000 U/ml) failed to activate peritoneal exudate MΦ from BALB/c micefor killling of L. major amastigotes. In the presence of suboptimal doses of IFN‐γ (5 or 10 U/ml), however, TNF‐α mediated a rapid elimination of intracellular parasites, which was highly significant compared to IFN‐γ alone. The combination of TNF with interleukin 4, in contrast, was inactive in this respect and allowed survival of intracellular parasites. From these data we conclude that thepresence of IFN‐γ is curcial for TNF‐α‐mediated killing of L. major parasites by MΦ. Disease progression in susceptible mice thereforeseems to be a consequence of a deficiency of IFN‐γ and a predominance of interleukin 4 rather than the result of an excess amount of TNF‐α.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/eji.1830200528

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding, A. H., Nathan, C., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,840
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
Kindler, V., Sappino, A., Grau, G. E., Piguet, P., & VASSALLI, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,239
ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE
Waage, A., Halstensen, A. I., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,085
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 876
Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
Wong, G. H., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 707
Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor
Munker, R., Gasson, J. C., Ogawa, M., & Koeffler, H. P. (1986) · Nature · doi:10.1038/323079a0 · Cited by 500
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
Murray, H. W., Rubin, B. Y., & Rothermel, C. D. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111107 · Cited by 403
Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez, L. E., & Young, L. S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.3006 · Cited by 379

Flagged first, then by citations

Show all 38 references

Research works printed but not linked: 6

Clark I. A., 1987, Am. J. Pathol., 129, 192
Bogdan C., 1989, Clin. Exp. Immunol., 75, 141
Streck H., 1987, Zbl. Bakt. Hyg. A., 265, 594
Green S., 1989, J. Leuk. Biol., 46, 306
Wirth J. J., 1989, Immunology, 66, 296
Mirkovich A. M., 1986, Clin. Exp. Immunol., 64, 1

Sorted by citations

T-cell quality in memory and protection: implications for vaccine design
Seder, R. A., Darrah, P. A., & Roederer, M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2274 · Cited by 1,565
Role of nitric oxide synthesis in macrophage antimicrobial activity
Nathan, C. F., & Hibbs, J. B. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90079-g · Cited by 1,523
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., Luca, P. M. D., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P. L., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,364
The immunology of susceptibility and resistance to Leishmania major in mice
Sacks, D. L., & Noben-Trauth, N. (2002) · Nature reviews. Immunology · doi:10.1038/nri933 · Cited by 1,205
Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major
Hu, S., Marshall, C., Darby, J. M., Wei, W., Lyons, A. B., & Körner, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00001 · Cited by 982
Cutaneous leishmaniasis: Immune responses in protection and pathogenesis
Scott, P., & Novais, F. O. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.72 · Cited by 591
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Lindenstrøm, T., Agger, E. M., Korsholm, K. S., Darrah, P. A., Aagaard, C., Seder, R. A., Rosenkrands, I., & Andersen, P. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801592 · Cited by 422
Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2
Becker, I., Salaiza, N., Aguirre, M., Delgado-Domínguez, J., Carrillo, N., Gutiérrez‐Kobeh, L., Ruiz, A., Cervantes-Sarabia, R. B., Torres, A. P., Cabrera, N., et al. (2003) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(03)00160-9 · Cited by 353
Immunology of Leishmaniasis
Liew, F. Y., & O’Donnell, C. A. (1993) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60208-0 · Cited by 334
Nonspecific defence mechanism: the role of nitric oxide
Liew, F. Y., & Cox, F. E. G. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80006-4 · Cited by 328
The Interaction of Leishmania Species with Macrophages
Alexander, J. K., & Russell, D. G. (1992) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60022-6 · Cited by 323
Synergism between tumor necrosis factor‐α and interferon‐γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide‐dependent mechanism
Muñoz‐Fernández, M. Á., Fernández, M. A., & Fresno, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220203 · Cited by 288
Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells
Moll, H., Fuchs, H., Blank, C., & Röllinghoff, M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230730 · Cited by 279
Self-citation
Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function
Locksley, R. M., & Scott, P. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80017-9 · Cited by 272
Cutaneous Manifestations of Human and Murine Leishmaniasis
Scorza, B. M., Carvalho, E. M., & Wilson, M. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061296 · Cited by 241
The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans
Schweizer, A., Rupp, S., Taylor, B. N., Röllinghoff, M., & Schröppel, K. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02132.x · Cited by 232
Self-citation
Effects of cytokines on intracellular growth of Brucella abortus
Jiang, X., & Baldwin, C. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.124-134.1993 · Cited by 224
Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages
Liew, F. Y., Li, Y., Moss, D., Parkinson, C., Rogers, M. V., & Moncada, S. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211216 · Cited by 197
Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism
Muñoz‐Fernández, M. Á., Fernández, M. A., & Fresno, M. (1992) · Immunology Letters · doi:10.1016/0165-2478(92)90090-b · Cited by 197
Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta.
Cunha, F. Q., Assreuy, J., Moss, D. W., Rees, D. D., Leal, L. M. C. C., Moncada, S., CARRIER, M. J., O'Donnell, C. A., & Liew, F. Y. (1994) · PubMed Central · Cited by 192
Rapidly Fatal Leishmaniasis in Resistant C57BL/6 Mice Lacking TNF
Wilhelm, P., Ritter, U., Labbow, S., Donhauser, N., Röllinghoff, M., Bogdan, C., & Körner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4012 · Cited by 184
Self-citation
Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination
Lewinsohn, D. A., Lewinsohn, D. M., & Scriba, T. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01262 · Cited by 176
Dendritic cells in Leishmania major‐immune mice harbor persistent parasites and mediate an antigen‐specific T cell immune response
Moll, H., Flohé, S. B., & Röllinghoff, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250310 · Cited by 172
Self-citation
Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose
Aagaard, C., Hoang, T. T. K. T., Izzo, A. A., Billeskov, R., Troudt, J. M., Arnett, K. A., Keyser, A., Elvang, T. T., Andersen, P. L., & Dietrich, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005930 · Cited by 166
Parasitism of Epidermal Langerhans Cells in Experimental Cutaneous Leishmaniasis withLeishmania major
Blank, C., Fuchs, H., Rappersberger, K., Röllinghoff, M., & Moll, H. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.2.418 · Cited by 153
Self-citation
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
Skeiky, Y. A. W., Guderian, J. A., Benson, D. R., Bacelar, O., Carvalho, E. M., Kubin, M. Z., Badaró, R. J. D. S., Trinchieri, G., & Reed, S. G. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1527 · Cited by 153
Migration Inhibitory Factor Induces Killing of Leishmania major by Macrophages: Dependence on Reactive Nitrogen Intermediates and Endogenous TNF-α
Jüttner, S., Bernhagen, J., Metz, C. N., Röllinghoff, M., Bucala, R., & Gessner, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2383 · Cited by 152
Self-citation
Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells
Müller, I., Kropf, P., Etges, R., & Louis, J. A. (1993) · Infection and Immunity · doi:10.1128/iai.61.9.3730-3738.1993 · Cited by 121
Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis
Chamizo, C., Moreno, J., & Alvar, J. (2004) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2004.08.010 · Cited by 111
Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice
Dey, R., Dagur, P. K., Selvapandiyan, A., McCoy, J. P., Salotra, P., DUNCAN, R. C., & Nakhasi, H. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202801 · Cited by 101
Cloning, characterization and overexpression of two iron superoxide dismutase cDNAs from Leishmania chagasi: role in pathogenesis1Note: L.c.FeSODA and L.c.SODB cDNA sequences have been assigned EMBL/GenBank™ data base accession numbers AF003964 and AF003963, respectively.1,2Note: A previous article on this same topic entitled `Molecular cloning, characterization and expression in Escherichia coli of iron superoxide dismutase cDNA from Leishmania donovani chagasi' by Ismail et al. which was published in Infect Immun 1994;62:657–664 has been retracted.2
Paramchuk, W. J., Ismail, S. O., Bhatia, A., & Gedamu, L. (1997) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00141-2 · Cited by 100
Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection
Locksley, R. M., Heinzel, F. P., Holaday, B. J., Mutha, S., Reiner, S. L., & Sadick, M. D. (1991) · Research in Immunology · doi:10.1016/0923-2494(91)90007-6 · Cited by 98
Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis
Guimarães, E. T., Lima, M. S., dos Santos, L. A. M., Ribeiro, I. M., Tomassini, T. C. B., dos Santos, R. R., dos‐Santos, W. L. C., & Soares, M. B. P. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp170 · Cited by 95
Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans
Skeiky, Y. A. W., Benson, D. R., Guderian, J. A., Whittle, J., Bacelar, O., Carvalho, E. M., & Reed, S. G. (1995) · Infection and Immunity · doi:10.1128/iai.63.10.4105-4114.1995 · Cited by 94
Sex Hormones and Modulation of Immunity against Leishmaniasis
Snider, H. M., Lezama-Dávila, C. M., Alexander, J. K., & Satoskar, A. R. (2009) · NeuroImmunoModulation · doi:10.1159/000180265 · Cited by 88
Leishmania Hijacks Myeloid Cells for Immune Escape
Martínez‐López, M., Soto, M., Iborra, S., & Sancho, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00883 · Cited by 90
Induction of macrophage nitric oxide production by interferon‐γ and tumor necrosis factor‐α is enhanced by interleukin‐10
Corradin, S. B., Fasel, N. J., Buchmüller-Rouiller, Y., Ransijn, A., Smith, J., & Mauël, J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230851 · Cited by 83
Protective Effect on Leishmania major Infection of Migration Inhibitory Factor, TNF-α, and IFN-γ Administered Orally via Attenuated Salmonella typhimurium
Xu, D., McSorley, S. J., Tetley, L., Chatfield, S. N., Dougan, G., Chan, W. L., Satoskar, A. R., David, J. R., & Liew, F. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1285 · Cited by 80
Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon‐γ to activate murine macrophages for killing of Leishmania major amastigotes
Bogdan, C., Stenger, S., Röllinghoff, M., & Solbach, W. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210213 · Cited by 79
Self-citation
Cytokines in Leishmaniasis: A Complex Network of Stimulatory and Inhibitory Interactions
Bogdan, C., Gessner, A., & Röllinghoff, M. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80366-9 · Cited by 80
Self-citation
Response of Leishmania chagasi promastigotes to oxidant stress
Wilson, M. E., Andersen, K. A., & Britigan, B. E. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.5133-5141.1994 · Cited by 75
Elongation Factor-2, a Th1 Stimulatory Protein of Leishmania donovani, Generates Strong IFN-γ and IL-12 Response in Cured Leishmania-Infected Patients/Hamsters and Protects Hamsters against Leishmania Challenge
Kushawaha, P. K., Gupta, R., Sundar, S., Sahasrabuddhe, A. A., & Dube, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102081 · Cited by 75
Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization — a Thomas Dougherty Award for Excellence in PDT paper
Silva, P. D., Saad, M. A., Thomsen, H., Bano, S., Ashraf, S., & Hasan, T. G. (2020) · Journal of Porphyrins and Phthalocyanines · doi:10.1142/s1088424620300098 · Cited by 73
Immune responses during cutaneous and visceral leishmaniasis
Kedzierski, Ł., & Evans, K. J. (2014) · Parasitology · doi:10.1017/s003118201400095x · Cited by 73
Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease‐promoting CD4+ cells are different from TH2 cells
Moll, H., & Röllighoff, M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200927 · Cited by 70
Self-citation
Elevation of rainbow trout Oncorhynchus mykiss macrophage respiratory burst activity with macrophage-derived supernatants
Jang, S. I., Hardie, L. J., & Secombes, C. J. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.6.943 · Cited by 68
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Saraf, A., Gurjar, R., Kaviraj, S., Kulkarni, A., Kumar, D., Kulkarni, R., Virkar, R., Krishnan, J., Yadav, A., Baranwal, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02955-2 · Cited by 66
Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo
Theodos, C. M., Povinelli, L., Molina, R., Sherry, B. A., & Titus, R. G. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2839-2842.1991 · Cited by 66
Interleukin‐10 Inhibits Antimicrobial Activity Against Leishmania major in Murine Macrophages
Vieth, M. W., Will, A., Schröppel, K., Röllinghoff, M., & Gessner, A. (1994) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1994.tb03481.x · Cited by 65
Self-citation
Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana.
Satoskar, A. R., & Alexander, J. K. (1995) · PubMed Central · Cited by 64
Ever closer to a prophylactic vaccine for HCV
Swadling, L., Klenerman, P., & Barnes, E. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.791277 · Cited by 57
Identifying vaccine targets for anti-leishmanial vaccine development
Sundar, S., & Singh, B. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.894467 · Cited by 58
Analysis of Cytokine mRNA Profiles in the Lungs of Pneumocystis carinii -infected Mice
Wright, T. W., Johnston, C. J., Harmsen, A. G., & Finkelstein, J. N. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.4.2851 · Cited by 57
Effector and Central Memory Poly-Functional CD4+ and CD8+ T Cells are Boosted upon ZOSTAVAX® Vaccination
Sei, J. J., Cox, K. S., Dubey, S. A., Antonello, J. M., Krah, D. L., Casimiro, D. R., & Vora, K. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00553 · Cited by 55
Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor‐α production by macrophages is induced by the synergistic action of interferon (IFN)‐γ and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN‐γ and IL 4
Stenger, S., Solbach, W., Röllinghoff, M., & Bogdan, C. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210713 · Cited by 55
Self-citation
The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain
Ritter, U., Mattner, J., Rocha, J. S., Bogdan, C., & Körner, H. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.008 · Cited by 53
Self-citation
Leishmania major parasite stage‐dependent host cell invasion and immune evasion
Wenzel, U. A., Bank, E., Florian, C., Förster, S., Zimara, N., Steinacker, J., Klinger, M., Reiling, N., Ritter, U., & van Zandbergen, G. (2012) · The FASEB Journal · doi:10.1096/fj.11-184895 · Cited by 52
Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-γ and TNF-α
Mauël, J., Ransijn, A., Corradin, S. B., & Buchmüller-Rouiller, Y. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.2.217 · Cited by 51
Susceptibility to Intracellular Infections: Contributions of TNF to Immune Defense
Li, X., Körner, H., & Liu, X. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01643 · Cited by 49
Both the Fas Ligand and Inducible Nitric Oxide Synthase Are Needed for Control of Parasite Replication within Lesions in Mice Infected withLeishmania majorwhereas the Contribution of Tumor Necrosis Factor Is Minimal
Chakour, R., Guler, R., Bugnon, M., Allenbach, C., Garcia, I., Mauël, J., Louis, J. A., & Tacchini‐Cottier, F. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5287-5295.2003 · Cited by 49
Phagocytosis enhances murine macrophage activation by interferon‐γ and tumor necrosis factor‐α
Corradin, S. B., Buchmüller-Rouiller, Y., & Mauël, J. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211036 · Cited by 49
An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection
Allenbach, C., Launois, P., Mueller, C., & Tacchini‐Cottier, F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737662 · Cited by 48
Antigen Presentation by Macrophages Harboring Intravesicular Pathogens
Overath, P., & Aebischer, T. (1999) · Parasitology Today · doi:10.1016/s0169-4758(99)01473-8 · Cited by 48
Murine epidermal Langerhans cells are potent stimulators of an antigen‐specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis
Will, A., Blank, C., Röllinghoff, M., & Moll, H. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220603 · Cited by 48
Self-citation
Leishmania-Infected Macrophages Are Targets of NK Cell-Derived Cytokines but Not of NK Cell Cytotoxicity
Prajeeth, C. K., Haeberlein, S., Sebald, H., Schleicher, U., & Bogdan, C. (2011) · Infection and Immunity · doi:10.1128/iai.00079-11 · Cited by 51
Self-citation
Inducing Humoral and Cellular Responses to Multiple Sporozoite and Liver-Stage Malaria Antigens Using Exogenous Plasmid DNA
Ferraro, B., Talbott, K. T., Balakrishnan, A., Cisper, N. J., Morrow, M. P., Hutnick, N. A., Myles, D. J. F., Shedlock, D. J., Obeng-Adjei, N., Yan, J., et al. (2013) · Infection and Immunity · doi:10.1128/iai.00180-13 · Cited by 48
Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod
El-On, J., Bazarsky, E., & Sneir, R. (2006) · Experimental Parasitology · doi:10.1016/j.exppara.2006.12.004 · Cited by 46
Antigen presentation by Leishmania mexicana‐infected macrophages: Activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites
Wolfram, M., Ilg, T., Mottram, J. C., & Overath, P. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250435 · Cited by 46
In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine
Song, H., Wittman, V., Byers, A. M., Tapia, T. M., Zhou, B., Warren, W., Heaton, P. M., & Connolly, K. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.044 · Cited by 45
Leishmania infantum: Mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice
Rolão, N., Cortes, S., Gomes‐Pereira, S., & Campino, L. (2006) · Experimental Parasitology · doi:10.1016/j.exppara.2006.09.013 · Cited by 44
Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental Leishmania chagasi infection
Cezário, G. A. G., de Oliveira, L. R. C., Peresi‐Lordelo, E., Nicolete, V. C., Polettini, J., de Lima, C. R. G., Gatto, M., & Calvi, S. A. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000500010 · Cited by 43
Proteomic analysis reveals differentially expressed proteins in macrophages infected with Leishmania amazonensis or Leishmania major
de Menezes, J. P. B., de Almeida, T. F., Petersen, A. L. O. A., Guedes, C. E. S., Mota, M. S., Lima, J. G. B., Palma, L. C., Buck, G. A., Krieger, M. A., Probst, C., et al. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.04.005 · Cited by 42
T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis
Costa-Madeira, J. C., Trindade, G. B., Almeida, P. H. P., Silva, J. S., & Carregaro, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835711 · Cited by 40
Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages
Gessner, A., Vieth, M. W., Will, A., Schröppel, K., & Röllinghoff, M. (1993) · Infection and Immunity · doi:10.1128/iai.61.9.4008-4012.1993 · Cited by 40
Self-citation
Suppression of type 2 NO-synthase activity in macrophages by Candida albicans
Schröppel, K., Kryk, M., i, M. H., Leberer, E., Röllinghoff, M., & Bogdan, C. (2001) · International Journal of Medical Microbiology · doi:10.1016/s1438-4221(01)80003-5 · Cited by 38
Self-citation
Cathepsin B in Antigen-Presenting Cells Controls Mediators of the Th1 Immune Response during Leishmania major Infection
Gonzalez-Leal, I. J., Röger, B., Schwarz, A., Schirmeister, T., Reinheckel, T., Lutz, M. B., & Moll, H. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003194 · Cited by 38
Self-citation
Murine epidermal Langerhans cells do not express inducible nitric oxide synthase
Blank, C., Bogdan, C., Bauer, C., Erb, K. J., & Moll, H. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260410 · Cited by 38
Self-citation
Heterologous priming–boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani
Guha, R., Das, S., Ghosh, J., Naskar, K., Mandala, A., Sundar, S., Dujardin, J., & Roy, S. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.025 · Cited by 37
Generation of TNFα, IFNγ, IL-6, IL-4 and IL-10 in mouse serum from trichinellosis: effect of the anti-inflammatory compound 4-deoxypyridoxine (4-DPD)
Frydas, S., Karagouni, E., Dotsika, E., Reale, M., Barbacane, R. C., Vlemmas, I., Anogianakis, G., Trakatellis, A., & Conti, P. (1996) · Immunology Letters · doi:10.1016/0165-2478(96)02501-1 · Cited by 37
A single dose polyanhydride-based nanovaccine against paratuberculosis infection
Thukral, A., Ross, K. A., Hansen, C. H., Phanse, Y., Narasimhan, B., Steinberg, H. N., & Talaat, A. M. (2020) · npj Vaccines · doi:10.1038/s41541-020-0164-y · Cited by 36
Potential biomarkers of immune protection in human leishmaniasis
Rostami, M. N., & Khamesipour, A. (2021) · Medical Microbiology and Immunology · doi:10.1007/s00430-021-00703-8 · Cited by 36
Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles
Mundayoor, S., Kumar, & Dhanasooraj (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40238 · Cited by 36
Leishmania Major Infection in Major Histocompatibility Complex Class II-Deficient Mice: CD8+ T Cells Do not Mediate a Protective Immune Response
Erb, K. J., Blank, C., Ritter, U., Bluethmann, H., & Moll, H. (1996) · Immunobiology · doi:10.1016/s0171-2985(96)80043-x · Cited by 36
Self-citation
Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL‐2 or IL‐4 is species and time dependent
Lezama-Dávila, C. M., WILLIAMS, D. M., Gallagher, G. E., & Alexander, J. K. (1992) · Parasite Immunology · doi:10.1111/j.1365-3024.1992.tb00004.x · Cited by 36
Prime–Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis
Junqueira‐Kipnis, A. P., de Oliveira, F. M., Trentini, M. M., Tiwari, S., Chen, B., Resende, D. P., Silva, B. D. S., Chen, M., Tesfa, L., Jacobs, W. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078639 · Cited by 35
Activated T Cells Induce Macrophages To Produce NO and ControlLeishmania majorin the Absence of Tumor Necrosis Factor Receptor p55
Nashleanas, M., & Scott, P. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1428-1434.2000 · Cited by 35
High Quality Long-Term CD4+ and CD8+ Effector Memory Populations Stimulated by DNA-LACK/MVA-LACK Regimen in Leishmania major BALB/c Model of Infection
Sánchez-Sampedro, L., Gómez, C. E., Mejías‐Pérez, E., Sorzano, C. Ó. S., & Estéban, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038859 · Cited by 34
Differentiation, regulation, and death of T helper cell subsets during infection with leishmania major
Scott, P. (1998) · Immunologic Research · doi:10.1007/bf02786447 · Cited by 33
Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenotype
Müller, I., Freudenberg, M. A., Kropf, P., Kiderlen, A. F., & Galanos, C. (1997) · Medical Microbiology and Immunology · doi:10.1007/s004300050048 · Cited by 33
Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response
Fromm, P. D., Kling, J. C., Remke, A., Bogdan, C., & Körner, H. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01520 · Cited by 32
Self-citation
Mast cells at the host–pathogen interface: host-protectionversusimmune evasion in leishmaniasis
Saha, B., Tonkal, A. M., Croft, S. L., & Roy, S. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02505.x · Cited by 32
Nonspecific defence the role of nitric oxide
Liew, F. Y., & Cox, F. E. G. (1991) · Parasitology Today · doi:10.1016/0169-4758(91)90023-h · Cited by 32
Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major
Flohé, S. B., Lang, T., & Moll, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3444-3450.1997 · Cited by 32
Self-citation
Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages
Chartouni, C. E., & Rehli, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.032 · Cited by 31
Immunology of murine leishmaniasis
McSorley, S. J., Proudfoot, L., O’Donnell, C. A., & Liew, F.-Y. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00037-5 · Cited by 31
IFN-γ-Dependent Recruitment of CD4 + T Cells and Macrophages Contributes to Pathogenesis During Leishmania amazonensis Infection
Carneiro, M. B. H., Lopes, M. E., Vaz, L. G., Sousa, L. M. A., dos Santos, L. M., de Souza, C. C., Campos, A. C. D. A., Gomes, D. A., Gonçalves, R., Tafuri, W. L., et al. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0043 · Cited by 30
IL-1β (−511T/C) gene polymorphism not IL-1β (+3953T/C) and LT-α (+252A/G) gene variants confers susceptibility to visceral leishmaniasis
Moravej, A., Rasouli, M., Kalani, M., Asaei, S., Kiany, S., Najafipour, S., Kouhpayeh, S. A., & Abdollahi, A. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1517-z · Cited by 30
Immunobiology of experimental leishmaniasis
M�ller, I., Fruth, U., & Louis, J. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00193391 · Cited by 29
Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis
Kossodo, S. D., Grau, G. E., Louis, J. A., & Müller, I. (1994) · Infection and Immunity · doi:10.1128/iai.62.4.1414-1420.1994 · Cited by 28
Role of cytokines in killing of intracellular pathogens
Liew, F. Y. (1991) · Immunology Letters · doi:10.1016/0165-2478(91)90024-5 · Cited by 27

Authors: Bogdan, C., Moll, H., Solbach, W., & Röllinghoff, M.
Affiliations: Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Corresponding author: Bogdan, Christian
ORCID: Bogdan, Christian
Moll, Heidrun
Solbach, Werner
Venue: European Journal of Immunology
Publisher: Wiley
Published: 1990-05
Volume: 20
Issue: 5
Pages: 1131-1135
ISSN: 0014-2980 (ISSN-L)
1521-4141
DOI: 10.1002/eji.1830200528
OpenAlex: W2081798138
Cited by: 183
References: 38
Citations by year: 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 6 · 2019: 1 · 2018: 10 · 2017: 4 · 2016: 4 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 7
FWCI: 19.49
Type: journal article
Language: en
Open access: green
opus.bibliothek.uni-wuerzburg.de
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 5679 d)
Locations: European Journal of Immunology (publishedVersion)
PubMed (publishedVersion)
Online Publication Service of Würzburg University (Würzburg University) (submittedVersion)
Funders: Deutsche Forschungsgemeinschaft
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
Keywords: TNF-α, interferon-gamma, IL-4, macrophage activation, Leishmania major, amastigotes, peritoneal macrophages, lipopolysaccharide, BALB/c mice, C57BL/6 mice, host-parasite interactions
MeSH terms: Animals, Drug Interactions, Female, Interferon-gamma, Kinetics, Leishmania tropica, Macrophages, Mice, Inbred BALB C, Tumor Necrosis Factor-alpha, Interleukin-4, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor necrosis factor‐α in combination with interferon‐γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks